Stay the Approval of any Pending Abbreviated New Drug Applications or New Drug Applications for Single Entity Products Containing Oxycodone Hydrochloride Unless the Conditions Specified in the Petition are Satisfied - CLOSED

Docket ID: FDA-2011-P-0433
Agency: Food and Drug Administration (FDA)
Parent Agency: Department of Health and Human Services (HHS)
Docket Details open glossary dialog  
Related RINs: None
Related Dockets: None
Keyword(s): cder, Oxycodone Hygrochloride , Single Entity Products
Type: Nonrulemaking
Docket Status: CLOSED
Center: CDER
Docket Item Code: P

Primary Documents

View All  (5)

Supporting Documents

No documents available.


No comments posted.

Comments Received*
*This count refers to the total comment/submissions received on this docket, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.